RiverNorth Capital and Income Fund, Inc. (NYSE:RSF – Get Free Report) declared a monthly dividend on Thursday, October 1st. Stockholders of record on Tuesday, December 15th will be given a dividend of $0.1371 per share on Thursday, December 31st. This represents a $1.65 dividend on an annualized basis and a dividend yield of 11.4%. The ex-dividend date is Tuesday, December 15th.
RiverNorth Capital and Income Fund has a dividend payout ratio of 85.0% indicating that its dividend is currently covered by earnings, but may not be in the future if the company’s earnings decline.
RiverNorth Capital and Income Fund Trading Up 0.6%
RSF traded up $0.08 on Friday, reaching $14.41. The company had a trading volume of 268 shares, compared to its average volume of 11,397. The business has a 50 day simple moving average of $14.48 and a 200 day simple moving average of $14.56. RiverNorth Capital and Income Fund has a 52-week low of $14.13 and a 52-week high of $15.07.
About RiverNorth Capital and Income Fund
RiverNorth Capital and Income Fund (NYSE: RSF) is a closed-end investment fund that seeks to provide a high level of current income and, secondarily, capital appreciation. The fund invests in a diversified portfolio of income-producing securities and credit-related assets.
Its portfolio may include public and private credit investments, senior secured loans, corporate debt, structured credit and other securities with income-generating potential. The fund uses a flexible investment approach that allows it to pursue opportunities across different sectors, issuers and levels of the credit market, while seeking to manage credit and interest-rate risk.
RiverNorth Capital and Income Fund is advised by RiverNorth Capital Management, LLC, an investment management firm specializing in income-oriented and alternative strategies.
Featured Stories
- Five stocks we like better than RiverNorth Capital and Income Fund
- Remitly’s September Pullback Tests a Still-Strong Growth Story
- Saddle Up: Texas Stock Exchange Ropes In $80 Billion in Listings
- Why Concentra’s Quiet Healthcare Business Keeps Winning
- Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup
Receive News & Ratings for RiverNorth Capital and Income Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RiverNorth Capital and Income Fund and related companies with MarketBeat.com's FREE daily email newsletter.
